tiprankstipranks
Trending News
More News >
Verona Pharma (VRNA)
:VRNA
US Market

Verona Pharma (VRNA) Ownership - Who Owns Verona Pharma?

Compare
Followers

Verona Pharma (VRNA) Ownership Overview

13.96%86.04%
86.04% Public Companies and Individual Investors
The ownership structure of Verona Pharma (VRNA) stock is a mix of institutional, retail, and individual investors. , and 86.04% is owned by Public Companies and Individual Investors.
The ownership structure of Verona Pharma (VRNA) stock is a mix of institutional, retail, and individual investors. , 13.96% is owned by Insiders

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,263,576Institution32.38%
12,176,144Insider14.08%1,295,907,006
1,810,000Institution13.75%
1,766,830Institution13.42%
11,264,968Insider13.02%1,198,930,544
1,132,800Institution8.60%
1,002,080Institution7.61%
615,352Institution4.67%
524,088Institution3.98%
521,859Institution3.96%

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,132,800Institution8.60%
411,916Institution3.13%
219,297Institution1.67%
150,818Institution1.15%
116,045Institution0.88%
115,100Institution0.87%
93,569Institution0.71%
88,532Institution0.67%
55,921Institution0.42%
50,000Institution0.38%

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Verona Pharma (VRNA)?
Currently, no data Available
What percentage of Verona Pharma (VRNA) stock is held by institutional investors?
Currently, no data Available
What percentage of Verona Pharma (VRNA) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.04% of Verona Pharma (VRNA) stock is held by retail investors.
    Who owns the most shares of Verona Pharma (VRNA)?
    David Costen Haley owns the most shares of Verona Pharma (VRNA).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.